Solubilization and stability of bumetanide in vehicles for intranasal administration, a pilot study.
The solubility of bumetanide in vehicles of various polarities, suitable for intranasal administration in acute situations, has been investigated. The solubility at 4 degrees C in glycofurol and polyethylene glycol 200 was high (167 and 143 mg/mL, respectively), decreasing exponentially with addition of phosphate buffer or coconut oil. Vehicles containing coconut oil and glycofurol did not seem to improve the solubility relative to mixtures between glycofurol and buffer. Adequate solubility (approximately 50 mg/mL) was achieved in vehicles containing about 80% cosolvent. The stability of bumetanide was studied at 5 degrees C and 57 degrees C. No degradation was observed at low temperature. At high temperature, bumetanide decomposes in nonaqueous vehicles with half-lifes ranging from 69 to 400 days, but sufficient stability may be obtained by adjustment of pH to 7.4. It may be concluded that it is possible to prepare a clinically relevant formulation for intranasal delivery of bumetanide.
Nielsen
H W
HW
Nycomed Danmark, Langebjerg 1, P.O. Box 88, DK-4000 Roskilde, Denmark.
Bechgaard
E
E
Twile
B
B
Didriksen
E
E
Almtorp
G T
GT
D000281:Administration, Intranasal; D002034:Bumetanide / Q000008:administration & dosage* / Q000737:chemistry; D004232:Diuretics / Q000008:administration & dosage*; D004355:Drug Stability; D014677:Pharmaceutical Vehicles; D012995:Solubility
D004232:Diuretics; D014677:Pharmaceutical Vehicles; D002034:Bumetanide